Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
Clinical trial NCT06722612 · RECRUITING
Trial details
- NCT number
- NCT06722612
- Sponsor
- Shu Wang
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-01
- Primary completion
- 2031-12-31
- Enrollment
- 2916
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.